CRIS Q1 2024 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-9.2% YoY

Gross Profit

$2M97.7% margin

Operating Income

-$12M-597.7% margin

Net Income

-$12M-569.3% margin

EPS (Diluted)

$-2.05

QoQ Revenue Growth

-22.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$62M

Total Liabilities

$53M

Stockholders' Equity

$9M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-9.2%
Gross Profit	$2M	$2M	-10.3%
Operating Income	-$12M	-$12M	-7.2%
Net Income	-$12M	-$12M	-2.7%